Antitubercular and antimicrobial activity of nh4vo3 promoted 1,4-dihydropyridine incorporated 1,3,4-Trisubstituted pyrazole

No Thumbnail Available

Date

2017

Journal Title

Journal ISSN

Volume Title

Publisher

Bentham Science Publishers B.V. P.O. Box 294 Bussum 1400 AG

Abstract

Background: A new series of pyrazole containing 1,4-dihydropyridine derivatives 5a-i and 6a-i were synthesized from substituted acetylated aryls and substituted phenylhydrazine by the multistep reaction. Method: The target compounds 1,4-dihydropyridine derivatives were obtained from green synthesis of 1,3-disubstituted phenyl-1H-pyrazole-4-carbaldehydes 4a-i with ethyl acetoacetate and methyl acetoacetate at higher temperatures in the presence of ammonium acetate and the catalytic amount of ammonium metavanadate (NH4VO3). The role of ammonium metavanadate was increases rate of the reaction and obtained high yields. Result: Structures of newly synthesized 1,4-dihydropyridine moiety containing pyrazole derivatives were confirmed by FT-IR, NMR and Mass spectral studies. The structure of compound 5b was confirmed by S-XRD study. Further, these compounds were tested for in-vitro antitubercular and antimicrobial studies. Compounds 5a, 5b, 5i, 6a, 6b, 6g, 6h, and 6i were found to be active against all the bacterial microorganisms. Conclusion: The above mentioned compounds have shown lowest MIC ranging between 3.12-12.5 ?g/ml against Mycobacterium tuberculosis and MIC values ranging between 7.8- 15.6 ?g/ml for Mycobacterium smegmatis, Staphylococcus aureus and Pseudomonas aeruginosa. For the control of life threatening diseases such as tuberculosis, these eight compounds may be strongly promising synthetic compounds. © 2017 Bentham Science Publishers.

Description

Keywords

1 phenyl 3 thiophen 2 yl 1h pyrazole 4 carbaldehyde, 1,4 dihydropyridine derivative, 2,6 dimethyl 4 (1 phenyl 3 thiophene 2 yl 1h pyrazol 4 yl) 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazole 4 carbaldehyde, 3 biphenyl 4 yl 1 (4 chlorophenyl) 1h pyrazole 4 carbaldehyde, 4 [1 (4 chlorophenyl) 3 (4 methoxyphenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [1 (4 chlorophenyl) 3 (4 methoxyphenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [1 (4 chlorophenyl) 3 para tolyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [1 (4 chlorophenyl) 3 para tolyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [1 (4 chlorophenyl) 3 thiophene 2 yl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [1 (4 chlorophenyl) 3 thiophene 2 yl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [1,3 bis(4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [1,3 bis(4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [3 (3 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [3 (3 bromophenyl) 1 phenyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [3 (3 bromophenyl) 1 phenyl 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [3 (4 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid diethylester, 4 [3 (4 bromophenyl) 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, 4 [3 biphenyl 4 yl 1 (4 chlorophenyl) 1h pyrazol 4 yl] 2,6 dimethyl 1,4 dihydropyridine 3,5 dicarboxylicacid dimethylester, ammonium vanadate, antibiotic agent, antifungal agent, ciprofloxacin, ethambutol, fluconazole, pyrazinamide, pyrazole derivative, streptomycin, tuberculostatic agent, unclassified drug, antibacterial activity, antifungal activity, antitubercular activity, Article, Candida albicans, carbon nuclear magnetic resonance, controlled study, crystal structure, drug activity, drug efficacy, drug mechanism, drug synthesis, drug targeting, green chemistry, high temperature, in vitro study, infrared spectroscopy, inhibition zone, mass spectrometry, minimum inhibitory concentration, Mycobacterium smegmatis, Mycobacterium tuberculosis, nonhuman, priority journal, proton nuclear magnetic resonance, Pseudomonas aeruginosa, reaction analysis, Staphylococcus aureus, structure activity relation, substitution reaction, X ray diffraction

Citation

Letters in Drug Design and Discovery, 2017, 14, 6, pp. 699-711

Collections

Endorsement

Review

Supplemented By

Referenced By